$TWST

11 stories mentioning TWSTUpdated 1d ago

Every FINWIRES story that references TWST, newest first.

What are analysts saying about TWST?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on TWST?

Sector Update: Healthcare Stocks Edge Lower Late Afternoon

Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fractionally down and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.The iShares Biotechnology ETF (IBB) was 0.2% lower.In corporate news, Novo Nordisk (NVO) is collaborating with AI firm Anthropic to try to address key drug discovery challenges, develop targeted solutions and accelerate the development of new medicines, the companies said Wednesday. Novo shares were shedding 2.4%.Twist Bioscience (TWST) shares gained 1.5% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI drug discovery platform created by Eli Lilly (LLY). Lilly shares were down 0.2%.Sanofi (SNY) said Wednesday it has opened the Charles Best Building flu vaccine manufacturing facility in the Sanofi Toronto campus that will make its Fluzone High-Dose influenza vaccine. Sanofi shares were up 0.5%.DataMEDS AI (MEDS) shares surged 305% after it said late Tuesday it has completed the acquisition of AI cancer diagnostics laboratory business Helomics Corporation from Axe Compute (AGPU).

$LLY$MEDS$NVO$SNY$TWST

Wire1d ago

Update: Twist Bioscience Shares Rise After Eli Lilly Drug Discovery Deal

(Updates with the latest stock price movement in the headline and the first paragraph.)Twist Bioscience (TWST) shares rose 3.5% in Wednesday trading after the company said it agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly (LLY).Under the agreement, TuneLab users can order Twist antibody services using preferred protocols to generate data for AI-enabled drug discovery models, including Lilly's AbLab antibody developability prediction model, the company said.Twist said the arrangement will connect experimental data with AI models and support more efficient selection of antibody candidates.Financial terms of the collaboration were not disclosed.Price: $142.96, Change: $+4.86, Percent Change: +3.52%

$LLY$TWST

Sectors1d ago

Sector Update: Healthcare Stocks Rise Wednesday Afternoon

Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.5%.The iShares Biotechnology ETF (IBB) rose 0.9%.In corporate news, Twist Bioscience (TWST) shares gained 4.2% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI drug discovery platform created by Eli Lilly (LLY). Lilly shares added 0.5%.Sanofi (SNY) said Wednesday it has opened the Charles Best Building flu vaccine manufacturing facility in the Sanofi Toronto campus that will make its Fluzone High-Dose influenza vaccine. Sanofi shares were up 0.9%.Novartis (NVS) discontinued development of VHB937 for amyotrophic lateral sclerosis, the company said in an emailed statement toWednesday. The decision was taken after a phase 2 Astrals study did not meet its primary or secondary endpoints. Novartis shares were fractionally higher.

$LLY$NVS$SNY$TWST

Sectors1d ago

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday

Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.9%.Twist Bioscience (TWST) stock was up more than 3% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly (LLY).Indivior Pharmaceuticals (INDV) and Reckitt Benckiser Healthcare have agreed to accelerate the termination date of their copacker supply agreement for Suboxone and Subutex tablets on Jan. 15, 2027, Indivior said in a regulatory filing. Shares of Indivior Pharmaceuticals were up more than 1% premarket.Abeona Therapeutics (ABEO) stock was up more than 2% after the company said the University of Florida Health in Gainesville has become the eighth Qualified Treatment Center for administering ZEVASKYN, its gene-modified cellular sheet therapy for wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa.

$ABEO$IBB$INDV$LLY$TWST$XLV

Sectors1d ago

Sector Update: Healthcare

Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) advancing by 0.9%.Twist Bioscience (TWST) stock was up more than 4% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly (LLY).

$LLY$TWST

Sectors29d ago

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 3.6%.The iShares Biotechnology ETF (IBB) climbed 6.3%.In sector news, President Donald Trump said Wednesday he has nominated Heidi Overton as the US Food and Drug Administration Commissioner. "We need her leadership at the FDA now to ensure that the US remains the WORLD LEADER for Scientific Discovery and CURES," Trump said in a post on Truth Social.In corporate news, Moderna (MRNA) shares surged 167% and Merck (MRK) shares jumped past 12% after the companies said a trial of intismeran autogene plus Keytruda met the primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in people with completely resected stage IIB-IV melanoma.Twist Bioscience (TWST) shares jumped nearly 20% after the company said Anthropic selected it as an independent evaluator for a multi-arm protein design project using AI.Sight Sciences (SGHT) shares climbed past 3% after the company said that the US Food and Drug Administration has updated the TearCare System's indication to include improving meibomian gland function in adult patients with evaporative dry eye disease caused by meibomian gland dysfunction.Teva Pharmaceutical Industries (TEVA) shares rose 2.1% after its US affiliate Teva Pharmaceuticals said Wednesday the US Food and Drug Administration has accepted its new drug application for ecopipam to potentially treat children with Tourette syndrome.

$MRK$MRNA$SGHT$TEVA$TWST

Sectors29d ago

Sector Update: Healthcare

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 3.6%.The iShares Biotechnology ETF (IBB) climbed 6.3%.In corporate news, Twist Bioscience (TWST) shares jumped past 21% after the company said Anthropic selected it as an independent evaluator for a multi-arm protein design project using AI.

$TWST

Wire45d ago

TD Cowen Raises Twist Bioscience Price Target to $115 From $89, Maintains Buy Rating

Twist Bioscience (TWST) has an average rating of buy and mean price target of $87.56, according to analysts polled by FactSet.Price: $95.66, Change: $+4.11, Percent Change: +4.49%

$TWST

Insider Trading83d ago

Twist Bioscience Insider Sold Shares Worth $1,793,600, According to a Recent SEC Filing

Emily M. Leproust, Director, Chief Executive Officer, on June 25, 2026, sold 18,880 shares in Twist Bioscience (TWST) for $1,793,600. Following the Form 4 filing with the SEC, Leproust has control over a total of 824,039 common shares of the company, with 824,039 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1581280/000121465926007800/xslF345X05/marketforms-73475.xml

$TWST

Research94d ago